Full Text View
Tabular View
No Study Results Posted
Related Studies
Dronabinol Versus Standard Ondansetron Antiemetic Therapy in Preventing Delayed-Onset Chemotherapy-Induced Nausea and Vomiting
This study has been completed.
Study NCT00642512   Information provided by Solvay Pharmaceuticals
First Received: March 21, 2008   Last Updated: March 31, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Additional conditions recognized in this trial
Nausea
Vomiting
More general conditions related to this trial
Signs and Symptoms
Signs and Symptoms, Digestive
Interventions listed in this trial
dronabinol
ondansetron
dronabinol/ondansetron
placebo
Additional drug interventions recognized in this trial
Tetrahydrocannabinol
More general drug interventions related to this trial
Analgesics
Analgesics, Non-Narcotic
Anti-Anxiety Agents
Antiemetics
Antipruritics
Antipsychotic Agents
Autonomic Agents
Central Nervous System Agents
Central Nervous System Depressants
Dermatologic Agents
Gastrointestinal Agents
Hallucinogens
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Sensory System Agents
Serotonin Agents
Serotonin Antagonists
Therapeutic Uses
Tranquilizing Agents
Sponsors listed in this trial
Solvay Pharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services